Literature DB >> 11529212

Human infection due to recombinant vaccinia-rabies glycoprotein virus.

C E Rupprecht1, L Blass, K Smith, L A Orciari, M Niezgoda, S G Whitfield, R V Gibbons, M Guerra, C A Hanlon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11529212     DOI： 10.1056/NEJMoa010560

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  38 in total

1.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 2.  Vaccinia virus vaccines: past, present and future.

Authors:  Bertram L Jacobs; Jeffrey O Langland; Karen V Kibler; Karen L Denzler; Stacy D White; Susan A Holechek; Shukmei Wong; Trung Huynh; Carole R Baskin
Journal:  Antiviral Res       Date:  2009-06-26       Impact factor: 5.970

3.  Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.

Authors:  Mark R Scheckelhoff; Sam R Telford; Linden T Hu
Journal:  Vaccine       Date:  2005-11-04       Impact factor: 3.641

4.  Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells.

Authors:  Ling Zhao; Harufusa Toriumi; Hualei Wang; Yi Kuang; Xiaofeng Guo; Kinjiro Morimoto; Zhen F Fu
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.

Authors:  Maarten J Voordouw; Haley Tupper; Özlem Önder; Godefroy Devevey; Christopher J Graves; Brian D Kemps; Dustin Brisson
Journal:  Vector Borne Zoonotic Dis       Date:  2013-02-21       Impact factor: 2.133

6.  Clinical experience, infection control practices and diagnostic algorithms for poxvirus infections - an Emerging Infections Network survey.

Authors:  Christine M Hughes; Edith R Lederman; Mary G Reynolds; Inger K Damon; R Ryan Lash; Susan E Beekmann; Philip M Polgreen
Journal:  BMC Res Notes       Date:  2010-02-25

7.  Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?

Authors:  Holger F Rabenau; Ingrid Rapp; Jochen Steinmann
Journal:  BMC Infect Dis       Date:  2010-06-23       Impact factor: 3.090

8.  Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus.

Authors:  Milosz Faber; Marie-Luise Faber; Jianwei Li; Mirjam A R Preuss; Matthias J Schnell; Bernhard Dietzschold
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

9.  Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.

Authors:  Aurelie Kern; Chensheng W Zhou; Feng Jia; Qiaobing Xu; Linden T Hu
Journal:  Vaccine       Date:  2016-08-05       Impact factor: 3.641

10.  Novel vaccines to human rabies.

Authors:  Hildegund C J Ertl
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.